Dr. Stacey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2255 Ygnacio Valley
Suite M
Walnut Creek, CA 94596Phone+1 925-930-7267
Education & Training
- University of WashingtonResidency, Internal Medicine, 1988 - 1991
- Emory University School of MedicineClass of 1988
Certifications & Licensure
- CA State Medical License 1999 - 2026
Clinical Trials
- Trenev Trio®/Healthy Trinity® for Recurrent Gastrointestinal Symptoms Start of enrollment: 2012 Feb 01
- PT/INR Reference Interval IN Healthy Volunteers Start of enrollment: 2014 Dec 01
Publications & Presentations
PubMed
- 1 citationsA Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-Experienced Adults 50 Years of Age or Older (STRIDE-6).Paul Scott, Miwa Haranaka, Jung Hyun Choi, Helen Stacey, Marc Dionne
Clinical Infectious Diseases. 2024-12-17 - 2 citationsCase report: Long-term follow-up of patients who received a FimCH vaccine for prevention of recurrent urinary tract infections caused by antibiotic resistant Enterobac...Elise Perer, Helen Stacey, Terri Eichorn, Heidi Hughey, Julie Lawrence
Frontiers in Immunology. 2024-01-01 - 14 citationsSafety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial.Joseph A Murray, Dina Wassaf, Karen Dunn, Samir Arora, Peter Winkle
The Lancet. Gastroenterology & Hepatology. 2023-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: